UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049449
Receipt number R000055544
Scientific Title YCU Early Detection Project of Pancreatic cancer led by EUS 2023- Prospective observational study on improvement 5 year survival rate
Date of disclosure of the study information 2022/12/01
Last modified on 2022/11/07 18:19:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

YCU Early Detection Project of Pancreatic cancer led by EUS 2023- Prospective observational study

Acronym

YCU Project 2023

Scientific Title

YCU Early Detection Project of Pancreatic cancer led by EUS 2023- Prospective observational study
on improvement 5 year survival rate

Scientific Title:Acronym

YCU Project 2023

Region

Japan


Condition

Condition

Pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To study and establish the strategy in the diagnosis of early pancreatic cancer diameter less than 10mm in diameter through the sessional cooperation system between YCU and primary care units in Yokohama south district's
This is 5-year prospective observational research aimed at evaluating the effect of elective EUS for pts with risks.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

5-year survival rate of the pts with pancreatic cancer in YCU hospital

Key secondary outcomes

The rate of early pancreatic cancers/The total number of outpatients with cancer risks


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Pts will have a planned EUS to investigate
pancreatic disorders.
Risks;
1)pts with abdominal pain or weight loss
2)abnormality of pancreatic enzyme
3)Elevation of tumor marker
4)Dilatation of pancreatic duct more than 2mm in diameter
5)pancreatic cyst
6)diffuse or focal swollen of the pancreas
7)Loacalized atarophy of the pancreas
8)new onset of DM or worsening DM
9)chroninc pancreatitis or autoimmune pancreatitis
10)family history of pancreatic disorders:
parenr, child or siblings)

Key exclusion criteria

1)mental disorders who can't judge the medical treatment.
2)pts who was assessed to be inappropriate as candidates by investigators.

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name kensuke
Middle name
Last name kubota

Organization

Yokohama City University Hospital

Division name

Endoscopic Unit

Zip code

236-0004

Address

Fukuura3-9, Kanazawa, Yokohama

TEL

045-787-2800

Email

kubotak@yokohama-cu.ac.jp


Public contact

Name of contact person

1st name kensuke
Middle name
Last name kubota

Organization

Yokoham City University Hpsopital

Division name

Endoscopic Unit

Zip code

236-0004

Address

3-9 Fukuura, Kanazawa,Yokohama

TEL

045-787-2800

Homepage URL


Email

kubotak@ykohama-cu.ac.jp


Sponsor or person

Institute

Endoscopic Unit, Yokohama City University Hospital

Institute

Department

Personal name



Funding Source

Organization

Yokohama City University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Yokohama City University Hospital

Address

3-9 Fukuura, Kanazawa, Yokohama

Tel

045-787-2800

Email

kubotak@yokohama-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 09 Month 07 Day

Date of IRB

2022 Year 10 Month 27 Day

Anticipated trial start date

2023 Year 01 Month 05 Day

Last follow-up date

2032 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective observatory study covered by health insurance of Japan.


Management information

Registered date

2022 Year 11 Month 07 Day

Last modified on

2022 Year 11 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055544


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name